The success of copyright’s blockbuster initially drove a boom for the drug industry, however recent shifts present a uncertain outlook for shareholders. Generic alternatives are eating into profits, and persistent https://shaunafflz840380.amoblog.com/the-blue-pill-and-pharma-a-volatile-play-63239986